Cyclic dinucleotide metal compound, and preparation and application thereof
US-2024317792-A1 · Sep 26, 2024 · US
Ultrasonic cancer treatment enhancer and cell killer
US8992958B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8992958-B2 |
| Application number | US-88320806-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 26, 2006 |
| Priority date | Oct 26, 2005 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
There is provided an ultrasonic cancer treatment enhancer and cell killer that can significantly improve the effect of treating cancer by ultrasonic irradiation while ensuring a high level of safety. The ultrasonic cancer treatment enhancer and cell killer comprise metal semiconductor particles and can be activated upon ultrasonic irradiation to kill or destruct cancer cells.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating cancer, characterized by administering a cell killer to an animal including human, and exposing cancer cells to ultrasonic waves of 400 KHz to 20 MHz after the administration to convert the cell killer to a cytotoxin, whereby the cytotoxin kills the cancer cells, wherein the cell killer comprises metal semiconductor particles and is convertible to the cytotoxin upon irradiation of ultrasonic waves of 400 KHz to 20 MHz, and the met…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K33/30Primary
Human Necessities · mapped topic
Operations & Transport · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8992958B2 cover?
- There is provided an ultrasonic cancer treatment enhancer and cell killer that can significantly improve the effect of treating cancer by ultrasonic irradiation while ensuring a high level of safety. The ultrasonic cancer treatment enhancer and cell killer comprise metal semiconductor particles and can be activated upon ultrasonic irradiation to kill or destruct cancer cells.
- Who is the assignee on this patent?
- Kanehira Koki, Sonezaki Shuji, Ogami Yumi, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K33/30. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).